Drug General Information
Drug ID
D05FEU
Former ID
DNC003380
Drug Name
6-ethoxy-1,3-benzothiazole-2-sulfonamide
Drug Type
Small molecular drug
Indication Duodenal ulcers [ICD10:K25-K27] Withdrawn from market [529372]
Structure
Download
2D MOL

3D MOL

Formula
C9H10N2O3S2
Canonical SMILES
CCOC1=CC2=C(C=C1)N=C(S2)S(=O)(=O)N
InChI
1S/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13)
InChIKey
OUZWUKMCLIBBOG-UHFFFAOYSA-N
CAS Number
CAS 452-35-7
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Carbonic anhydrase II Target Info Inhibitor [551374]
KEGG Pathway Nitrogen metabolism
Proximal tubule bicarbonate reclamation
Collecting duct acid secretion
Gastric acid secretion
Pancreatic secretion
Bile secretion
NetPath Pathway IL4 Signaling Pathway
EGFR1 Signaling Pathway
Reactome Erythrocytes take up carbon dioxide and release oxygen
Erythrocytes take up oxygen and release carbon dioxide
Reversible hydration of carbon dioxide
WikiPathways Reversible Hydration of Carbon Dioxide
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
References
Ref 529372The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents. Curr Pharm Des. 2008;14(7):649-54.
Ref 551374The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.